BioPharmaSpec
Loren Bossert has been working as a Scientist at BioPharmaSpec since May 2022, following an internship as a Lab Technician at the Pennsylvania Equine Toxicology & Research Laboratory from October 2020 to January 2022. Loren holds a Bachelor of Science degree in Forensic & Toxicological Chemistry from West Chester University of Pennsylvania, completed in May 2022.
BioPharmaSpec
BioPharmaSpec is a UK and US based CRO providing structural and physicochemical protein characterization services. We help our clients get their biopharmaceutical products into clinical trials more cost effectively and quickly. Our technical expertise includes the structural characterization and physicochemical analysis of recombinant biopharmaceuticals such as biosimilars and biobetters, monoclonal antibodies, Antibody Drug Conjugates (ADCs), blood circulating hormones, gene therapy products and oligonucleotide therapeutics. Using state-of-the-art Chromatographic and Mass Spectrometric instrumentation and methods, BioPharmaSpec applies expertise built up over 45 years of pioneering research, to assist clients in a number of protein characterization methods including Primary Amino Acid Sequencing, N and C terminal sequencing, Amino Acid Analysis, Peptide Mapping, Disulfide Bridge analysis, Glycan analysis and Higher Order Structure of proteins. Our analytical data helps you choose the best cell clone, provide batch to batch comparisons or perform biosimilar testing for biosimilarity and comparability studies. With BioPharmaSpec's support, solid development decisions can be made based on quality analytical data and experience.